REPORT | Consulting Why Are Drug Manufacturers Cutting List Prices? Inside the 2026 WAC Reduction Trend In January 2026, seven brand-name drugs without generic competition took Wholesale Acquisition...
Read More
REPORT | Consulting The Complete Guide to Direct to Patient (DTP) Drug Programs: Strategy, Economics, and Affordability Integration Direct to Patient (DTP) programs are transforming how drug manufacturers...
Read More
REPORT | Consulting ACE-ing Launch Success Unlocking the true drivers of patient access, experience, and conversion Successful drug launches hinge on whether patients can actually access and start...
Read More
REPORT | AI 5 Ways AI is Actually Impacting Pharma Launches Download PDF Explore Our Insights
Read More
SPECIAL REPORT | In Conjunction with ASCO 2026 Is Oncology Ready? Four Forces Defining the Next Five Years Download PDF Explore Our Insights
Read More
